Servier· @Servier · X·· 2026-10-06AI 评分8
AI 导读
施维雅在EANS2026神经外科年会上与欧洲及国际神经外科界交流,探讨神经科学领域的挑战与机遇。公司称其研发预算近70%投入肿瘤研究,重点关注未满足医疗需求显著的癌症。
正文
#EANS2026 has come to an end!
We were delighted to connect with the European and international neurosurgical community, share perspectives, and discuss the challenges and opportunities ahead in neuroscience.
In line with our #Servier2030 strategy, we invest close to 70% of our R&D budget in oncology research 🔬, with a particular focus on cancers where significant unmet medical needs remain.
Learn more about our commitment to oncology 🔗 https://f.mtr.cool/b8j8u8ezz4
#WeAreServier #MovedByYou #Neuroscience #Neurosurgery @EANSonline50
来源:Servier · x.com